Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
The New England Journal of Medicine|May 24, 2020
Remdesivir for the Treatment of Covid-19 - Final ReportJohn H Beigel, Kay M Tomashek, Lori E Dodd, et al.
Open Forum Infectious Diseases|June 29, 2023
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test CaseAna M Ortega-Villa, Noreen A Hynes, Corri B Levine, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 28, 2021
A Comparison of Less Invasive Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Diagnostic Specimens in Nursing Home Residents-Arkansas, June-August 2020Paige Gable, Jennifer Y Huang, Sarah E Gilbert, et al.
JAMA|April 7, 2025
Invasive Group A Streptococcal Infections in 10 US StatesChristopher J Gregory, Jennifer Onukwube Okaro, Arthur Reingold, et al.
Plos One|October 19, 2020
The epidemiology and estimated etiology of pathogens detected from the upper respiratory tract of adults with severe acute respiratory infections in multiple countries, 2014-2015Jennifer Milucky, Tracy Pondo, Christopher J Gregory, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 27, 2026
Epidemiology of Pediatric Invasive Group A Streptococcal Infections in 10 U.S. States, 2004-2023Veena Ramachandran, Jennifer Onukwube Okaro, Namrata Prasad, et al.
Emerging Infectious Diseases|January 30, 2026
Group A Streptococcus Meningitis, United States, 1997-2022Paulina A Hawkins, Sopio Chochua, Namrata Prasad, et al.
Annals of Internal Medicine|November 28, 2022
Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment TrialGail E Potter, Tyler Bonnett, Kevin Rubenstein, et al.
The New England Journal of Medicine|December 11, 2020
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19Andre C Kalil, Thomas F Patterson, Aneesh K Mehta, et al.
The Lancet. Respiratory Medicine|October 21, 2021
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trialAndre C Kalil, Aneesh K Mehta, Thomas F Patterson, et al.
Pageof 13